165 related articles for article (PubMed ID: 30725419)
1. Pilot Phase I Clinical Trial of Methioninase on High-Stage Cancer Patients: Rapid Depletion of Circulating Methionine.
Hoffman RM; Tan Y; Li S; Han Q; Zavala J; Zavala J
Methods Mol Biol; 2019; 1866():231-242. PubMed ID: 30725419
[TBL] [Abstract][Full Text] [Related]
2. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients.
Tan Y; Zavala J; Han Q; Xu M; Sun X; Tan X; Tan X; Magana R; Geller J; Hoffman RM
Anticancer Res; 1997; 17(5B):3857-60. PubMed ID: 9427792
[TBL] [Abstract][Full Text] [Related]
3. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients.
Tan Y; Zavala J; Xu M; Zavala J; Hoffman RM
Anticancer Res; 1996; 16(6C):3937-42. PubMed ID: 9042316
[TBL] [Abstract][Full Text] [Related]
4. Development of Recombinant Methioninase for Cancer Treatment.
Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy.
Tan Y; Xu M; Tan X; Tan X; Wang X; Saikawa Y; Nagahama T; Sun X; Lenz M; Hoffman RM
Protein Expr Purif; 1997 Mar; 9(2):233-45. PubMed ID: 9056489
[TBL] [Abstract][Full Text] [Related]
6. Methioninase Gene Therapy.
Hoffman RM; Miki K; Al-Refaie W; Xu M; Tan Y
Methods Mol Biol; 2019; 1866():173-197. PubMed ID: 30725416
[TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy.
Tan Y; Sun X; Xu M; An Z; Tan X; Han Q; Miljkovic DA; Yang M; Hoffman RM
Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456
[TBL] [Abstract][Full Text] [Related]
8. Safety and Toxicity of Recombinant Methioninase and Polyethylene Glycol (PEG) Recombinant Methioninase in Primates.
Hoffman RM; Yang Z; Tan Y; Han Q; Li S; Yagi S
Methods Mol Biol; 2019; 1866():211-229. PubMed ID: 30725418
[TBL] [Abstract][Full Text] [Related]
9. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
Miki K; Al-Refaie W; Xu M; Jiang P; Tan Y; Bouvet M; Zhao M; Gupta A; Chishima T; Shimada H; Makuuchi M; Moossa AR; Hoffman RM
Cancer Res; 2000 May; 60(10):2696-702. PubMed ID: 10825143
[TBL] [Abstract][Full Text] [Related]
10. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey.
Hoffman RM
Expert Opin Biol Ther; 2015 Jan; 15(1):21-31. PubMed ID: 25439528
[TBL] [Abstract][Full Text] [Related]
11. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate.
Yang Z; Sun X; Li S; Tan Y; Wang X; Zhang N; Yagi S; Takakura T; Kobayashi Y; Takimoto A; Yoshioka T; Suginaka A; Frenkel EP; Hoffman RM
Cancer Res; 2004 Aug; 64(16):5775-8. PubMed ID: 15313919
[TBL] [Abstract][Full Text] [Related]
12. Survival efficacy of the combination of the methioninase gene and methioninase in a lung cancer orthotopic model.
Miki K; Xu M; An Z; Wang X; Yang M; Al-Refaie W; Sun X; Baranov E; Tan Y; Chishima T; Shimada H; Moossa AR; Hoffman RM
Cancer Gene Ther; 2000 Feb; 7(2):332-8. PubMed ID: 10770644
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes L-methioninase.
El-Sayed AS; Shouman SA; Nassrat HM
Enzyme Microb Technol; 2012 Sep; 51(4):200-10. PubMed ID: 22883554
[TBL] [Abstract][Full Text] [Related]
14. Afterword: Oral Methioninase-Answer to Cancer and Fountain of Youth?
Hoffman RM; Han Q; Kawaguchi K; Li S; Tan Y
Methods Mol Biol; 2019; 1866():311-322. PubMed ID: 30725426
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.
Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Murakami T; Unno M; Hoffman RM
Cells; 2019 May; 8(5):. PubMed ID: 31052611
[TBL] [Abstract][Full Text] [Related]
17. High Efficacy of Recombinant Methioninase on Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Cancer.
Hoffman RM; Murakami T; Kawaguchi K; Igarashi K; Tan Y; Li S; Han Q
Methods Mol Biol; 2019; 1866():149-161. PubMed ID: 30725414
[TBL] [Abstract][Full Text] [Related]
18. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells In Vitro.
Tan Y; Xu M; Hoffman RM
Anticancer Res; 2010 Apr; 30(4):1041-6. PubMed ID: 20530407
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primates.
Yang Z; Wang J; Yoshioka T; Li B; Lu Q; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
Clin Cancer Res; 2004 Mar; 10(6):2131-8. PubMed ID: 15041734
[TBL] [Abstract][Full Text] [Related]
20. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
